Topic: shareholder lawsuits
The proposed settlement would effectively erase NantCell’s investment in Precision Biologics.
The delisting plan of Chinese vaccine maker Sinovac has been complicated by a bribery case and a new bid.
Altor shareholders, revolting against Patrick Soon-Shiong's deal to buy the company, are going to court to block it.
Theranos settled two lawsuits with Partner Fund Management, which backed the embattled blood-testing startup with a $96.1 million investment in 2014.
Medtronic may have closed its $50 billion tax inversion deal with Covidien last year, but not everyone is popping the bubbly. A group of shareholders is trying to throw a wrench into the deal by suing the devicemaker in Minnesota Supreme Court.
